Pamela L Donner

This inventor holds 26 USPTO granted patents and 6 published patent applications, plus 9 CIPO patents and 17 EPO patents, primarily in Antiviral Compounds. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Reata Pharmaceuticals, Inc.. Active years: 2010-2018.

USPTO Granted Patents = 26 (Patent Applications = 6)

% Patents Active = 96.2

CIPO Patents = 9 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 15.2

ph-index = 8

Forward Citations = 236(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

1 out of 63

Reata Pharmaceuticals, Inc.

patents

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2018

Loading Chart...

Areas of Expertise:

Anti-Viral Compounds

Anti-Infective Agents

Inflammation Modulators

Pyrazolyl

Pyrimidinyl

Tricyclic Enones

Antioxidants

Biomedical Innovations

Pharmaceutical Applications

Compound Uses

Inflammation

Infection Control

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10039754 - Anti-viral compounds (2018-08-07),

2. 10028937 - Anti-viral compounds (2018-07-24),

3. 9637478 - Antiviral compounds and uses thereof (2017-05-02),

4. 9586978 - Anti-viral compounds (2017-03-07),

5. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2016-10-11),

6. 9353091 - Antiviral compounds and uses thereof (2016-05-31),

7. 9278922 - Anti-viral compounds (2016-03-08),

8. 9249138 - Anti-viral compounds (2016-02-02),

9. 9163017 - Anti-viral compounds (2015-10-20),

10. 9139536 - Anti-infective agents and uses thereof (2015-09-22),

11. 9006387 - Anti-viral compounds (2015-04-14),

12. 8986740 - Anti-infective agents and uses thereof (2015-03-24),

13. 8937150 - Anti-viral compounds (2015-01-20),

14. 8921514 - Anti-viral compounds (2014-12-30),

15. 8748443 - Antiviral compounds and uses thereof (2014-06-10),

Title: Innovator Spotlight: Pamela L Donner - Pioneering Anti-Viral Compounds Inventor

Introduction:

Pamela L Donner, a notable inventor based in Mundelein, IL (US), has made significant contributions to the field of antiviral compounds. With a remarkable portfolio of 26 patents, Donner has been at the forefront of innovative solutions in inhibiting the replication of the Hepatitis C virus (HCV).

Latest Patents:

Donner's latest patents focus on describing compounds that effectively inhibit the replication of the HCV. These inventions also encompass processes for producing such compounds, compositions containing them, and methods for utilizing these compounds in the treatment of HCV infections.

Career Highlights:

Throughout her career, Pamela L Donner has been associated with esteemed companies such as AbbVie Inc. and Abbott Laboratories Corporation. Her dedication to research and development has led to groundbreaking discoveries in the pharmaceutical industry, particularly in the realm of antiviral treatments.

Collaborations:

Donner has collaborated with notable peers in the field, including Allan C Krueger and David A DeGoey. These collaborations have synergistically contributed to the advancement of innovative antiviral technologies, further solidifying Donner's reputation as a pioneering inventor.

Conclusion:

In conclusion, Pamela L Donner's relentless pursuit of innovation in antiviral compounds has not only resulted in a substantial patent portfolio but has also significantly impacted the medical field's ability to combat HCV infections. Her invaluable contributions exemplify the essence of ingenuity and dedication in the realm of pharmaceutical inventions.